ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,740.01
      -0.09%
      US Tech 100
      19,472.80
      -0.54%
      Dow Jones
      42,325.78
      0.36%
      Brent Oil
      71.945
      1.40%
      Bitcoin
      65,693.87
      0.78%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vanda Pharmaceuticals Inc (VNDA)

      7. Vanda Pharmaceuticals Inc (VNDA) News

      VNDA

      Vanda Pharmaceuticals (VNDA)

      Vanda Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VNDA
      DateTimeSourceHeadlineSymbolCompany
      09/19/20248:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
      09/19/20247:00AMPR Newswire (US)FDA Declines to Approve Vanda's Marketing Application for Tradipitant in GastroparesisNASDAQ:VNDAVanda Pharmaceuticals Inc
      09/11/20245:00PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
      09/04/20245:13PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
      08/29/20244:30PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
      08/08/20247:47AMEdgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:VNDAVanda Pharmaceuticals Inc
      08/08/20247:29AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
      08/01/20247:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VNDAVanda Pharmaceuticals Inc
      07/31/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
      07/31/20244:01PMPR Newswire (US)Vanda Pharmaceuticals Reports Second Quarter 2024 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
      07/29/20245:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
      07/29/20245:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
      07/26/20249:19AMPR Newswire (US)Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:VNDAVanda Pharmaceuticals Inc
      07/01/20248:01AMPR Newswire (US)Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and ApotexNASDAQ:VNDAVanda Pharmaceuticals Inc
      06/19/20248:48PMPR Newswire (US)Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its ShareholdersNASDAQ:VNDAVanda Pharmaceuticals Inc
      06/13/20244:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
      06/13/202410:02AMPR Newswire (US)Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future PakNASDAQ:VNDAVanda Pharmaceuticals Inc
      06/06/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
      06/06/20249:24AMPR Newswire (US)Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.NASDAQ:VNDAVanda Pharmaceuticals Inc
      05/30/20245:20PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/30/20244:48PMPR Newswire (US)Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®NASDAQ:VNDAVanda Pharmaceuticals Inc
      05/29/20242:17PMPR Newswire (US)Vanda Pharmaceuticals Announces Presentations at SLEEP 2024NASDAQ:VNDAVanda Pharmaceuticals Inc
      05/24/20244:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/24/20244:46PMPR Newswire (US)Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its ShareholdersNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/24/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/24/20244:31PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VNDAVanda Pharmaceuticals Inc
      05/21/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/21/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/21/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
      05/21/20244:34PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VNDAVanda Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:VNDA

      Your Recent History

      EU
      Q438S
      Q438S
      Delayed Upgrade Clock